Effect of chondroitin sulfate and hyaluronic acid (500-730 kDa) on synthesis of stromelysin (MMP-3) and MMP-1 in human chondrocyte cultures;Efecto de condroitín sulfato y ácido hialurónico (500-730 kDa) sobre la síntesis de estromelisina (MMP-3) y MMP-1 en cultivo de condrocitos humanos

Reumatologia Clinica

Volumn 1, Issue 3, 2005, Pages 150-154

  Monfort, J ^a   Nacher, M ^b   Montell, E ^c   Tomas E ^c   Verges J ^c   Benito, P ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c Científico Bioibérica Farma Barcelona España   (Spain)

Author keywords

Chondroitin sulfate; Hyaluronic acid; Metalloproteases; Osteoarthritis

Indexed keywords

EID: 77949782951     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/S1699-258X(05)72734-0     Document Type: Article

References (15)

1. Murphy G., Knäuper V., Atkinson S., Butler G., English W., Hutton M., et al. Matrix metalloproteinases in arthritic disease. Arthritis Res 4 (2002) S39-S49
2. Fuchs S., Skwara A., Bloch M., and Dankbar B. Differential induction and regulation of matrix metalloproteinases in osteoarthritic tissue and fluid synovial fibroblasts. Osteoarthritis Cartilage 12 (2004) 409-418
3. Morreale P., Manopulo R., Galati M., Boccanera L., Saponati G., and Bocchi L. Comparison of the antiinflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis. J Rheumatol 23 (1996) 1385-1391
4. ®) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. J Rheumatol 25 (1998) 2203-2212
5. Jordan K.M., Arden N.K., Doherty M., Bannwarth B., Bijlsma J.W., Dieppe P., et al. Standing Committee for International Clinical Studies Including Therapeutic Trials ESCISIT. EULAR Recommendations 2003: an evidenced based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 62 (2003) 1145-1155
6. Ronca F., Palmieri L., Panicucci P., and Ronca G. Anti-inflammatory activity of chondroitin sulfate. Osteoarthritis Cartilage 6 Suppl A (1998) 14-21
7. Bali J.P., Cousse H., and Neuzil E. Biochemical basis of the pharmacologic action of chondroitin sulfates on the osteoarticular system. Semin Arthritis Rheum 31 (2001) 58-68
8. Maneiro E., De Andrés M.C., Fernández-Sueiro J.L., Galdo F., and Blanco F.J. The biological action of hyaluronan on human OA articular chondrocytes: the importance of molecular weight. Clin Exp Rheumatol 22 (2004) 307-312
9. Vignon E., Mazieres B., Richard M., and Annefeld M. In vitro evaluation of a chondroprotector. Rev Rhum Mal Osteoartic 57 (1990) 15S-18S
10. Homandberg G.A., Hui F., Wen C., Kuettner K.E., and Williams J.M. Hyaluronic acid suppresses fibronectin fragment mediated cartilage chondrolysis in vitro. Osteoarthritis Cartilage 5 (1997) 309-319
11. Han F., Ishiguro N., Ito T., Sakai T., and Iwata H. Effects of sodium hyaluronate on experimental osteoarthritis in rabbit knee joints. Nagoya J Med Sci 62 (1999) 115-126
12. Julovi S.M., Yasuda T., Shimizu M., Hiramitsu T., and Nakamura T. Inhibition of interleukin-1beta-stimulated production of matrix metalloproteinases hyaluronan via CD44 in human articular cartilage. Arthritis Rheum 50 (2004) 516-525
13. Wang L., Wang J., Almqvist K.F., Veys E.M., and Verbruggen G. Influence of polysulphated polysaccharides and hydrocortisone on the extracellular matrix metabolism of human articular chondrocytes in vitro. Clin Exp Rheumatol 20 (2002) 669-676
14. Li Z., Hou W.S., and Bromme D. Collagenolytic activity of cathepsin K is specifically modulated by cartilage-resident chondroitin sulfates. Biochemistry 39 (2000) 529-536
15. Tardif G., Pelletier J.P., Dupuis M., Geng C., Cloutier J.M., and Martel-Pelletier J. Collagenase 3 production by human osteoarthritic chondrocytes in response to growth factors and cytokines is a function of the physiologic state of the cells. Arthritis Rheum 42 (1999) 1147-1169